215 related articles for article (PubMed ID: 23226285)
1. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
2. MLH1-93G > A is a risk factor for MSI colorectal cancer.
Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
[TBL] [Abstract][Full Text] [Related]
3. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
4. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.
Allan JM; Shorto J; Adlard J; Bury J; Coggins R; George R; Katory M; Quirke P; Richman S; Scott D; Scott K; Seymour M; Travis LB; Worrillow LJ; Bishop DT; Cox A; ;
Int J Cancer; 2008 Nov; 123(10):2456-9. PubMed ID: 18712731
[TBL] [Abstract][Full Text] [Related]
5. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.
Nizam ZM; Abdul Aziz AA; Kaur G; Abu Hassan MR; Mohd Sidek AS; Yeh LY; Mazuwin M; Ankathil R
Asian Pac J Cancer Prev; 2013; 14(2):619-24. PubMed ID: 23621208
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.
Perera S; Mrkonjic M; Rawson JB; Bapat B
Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982
[TBL] [Abstract][Full Text] [Related]
8. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
[TBL] [Abstract][Full Text] [Related]
9. The dynamic DNA methylation landscape of the
Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
[TBL] [Abstract][Full Text] [Related]
10. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
[TBL] [Abstract][Full Text] [Related]
11. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Hubner RA; Houlston RS
J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
[No Abstract] [Full Text] [Related]
12. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.
Xu JL; Yin ZQ; Huang MD; Wang XF; Gao W; Liu LX; Wang RS; Huang PW; Yin YM; Liu P; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):901-7. PubMed ID: 22631669
[TBL] [Abstract][Full Text] [Related]
13. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
[TBL] [Abstract][Full Text] [Related]
14. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.
Campbell PT; Curtin K; Ulrich CM; Samowitz WS; Bigler J; Velicer CM; Caan B; Potter JD; Slattery ML
Gut; 2009 May; 58(5):661-7. PubMed ID: 18523027
[TBL] [Abstract][Full Text] [Related]
16. MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features.
Li X; Yao X; Wang Y; Hu F; Wang F; Jiang L; Liu Y; Wang D; Sun G; Zhao Y
PLoS One; 2013; 8(3):e59064. PubMed ID: 23555617
[TBL] [Abstract][Full Text] [Related]
17. Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis.
Chen H; Shen Z; Hu Y; Xiao Q; Bei D; Shen X; Ding K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2147-58. PubMed ID: 25986311
[TBL] [Abstract][Full Text] [Related]
18. MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer.
Muñiz-Mendoza R; Ayala-Madrigal ML; Partida-Pérez M; Peregrina-Sandoval J; Leal-Ugarte E; Macías-Gómez N; Peralta-Leal V; Meza-Espinoza JP; Moreno-Ortiz JM; Ramírez-Ramírez R; Suárez-Villanueva S; Gutiérrez-Angulo M
Genet Mol Res; 2012 Aug; 11(3):2315-20. PubMed ID: 22843073
[TBL] [Abstract][Full Text] [Related]
19. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.
Levine AJ; Win AK; Buchanan DD; Jenkins MA; Baron JA; Young JP; Long TI; Weisenberger DJ; Laird PW; McCall RL; Duggan DJ; Haile RW
Cancer Prev Res (Phila); 2012 Feb; 5(2):328-35. PubMed ID: 22144422
[TBL] [Abstract][Full Text] [Related]
20. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
